Seizure Freedom And Patient Retention With Adjunctive Eslicarbazepine Acetate Therapy In Adults With Refractory Partial Seizures During Three Randomized, Double-Blind, Placebo-Controlled Trials With 1-Year, Open-Label Extensions
AuthID
P-003-61B
P-003-61B